Serological Test News and Research

RSS
Seroprevalence study reveals high exposure to SARS-CoV-2 in Bangui population

Seroprevalence study reveals high exposure to SARS-CoV-2 in Bangui population

WHO’s C-TAP and MPP finalize licensing agreement with CSIC for COVID-19 serological antibody technology

WHO’s C-TAP and MPP finalize licensing agreement with CSIC for COVID-19 serological antibody technology

The impact of interventions and contact patterns on SARS-CoV-2 transmission

The impact of interventions and contact patterns on SARS-CoV-2 transmission

New Canadian serology solution for SARS-CoV-2 infections and vaccination

New Canadian serology solution for SARS-CoV-2 infections and vaccination

Sero-epidemiological insights into pathways to COVID-19 immunity

Sero-epidemiological insights into pathways to COVID-19 immunity

Chilblain-like lesions and COVID-19

Chilblain-like lesions and COVID-19

Quantification of antibody titers against SARS-CoV-2 variants elicited by BNT162b2 vaccine

Quantification of antibody titers against SARS-CoV-2 variants elicited by BNT162b2 vaccine

A novel FACS-based approach for SARS-CoV-2 serology

A novel FACS-based approach for SARS-CoV-2 serology

Neuropsychiatric symptoms in children and adolescents with long COVID

Neuropsychiatric symptoms in children and adolescents with long COVID

What are the challenges of SARS-CoV-2 serosurveillance in COVID-19 vaccine recipients?

What are the challenges of SARS-CoV-2 serosurveillance in COVID-19 vaccine recipients?

SARS-CoV-2 virus persistence in immunocompromised individuals

SARS-CoV-2 virus persistence in immunocompromised individuals

Researchers conduct a SARS-CoV-2 serosurvey of blood donors in New Zealand

Researchers conduct a SARS-CoV-2 serosurvey of blood donors in New Zealand

Study shows antibody responses persisting 10 months after SARS-CoV-2 infection

Study shows antibody responses persisting 10 months after SARS-CoV-2 infection

SARS-CoV-2 D614G mutation associated with lower antibody binding

SARS-CoV-2 D614G mutation associated with lower antibody binding

New platform for detecting and monitoring SARS-CoV-2 antibody responses

New platform for detecting and monitoring SARS-CoV-2 antibody responses

How feasible is at-home antibody testing for COVID-19?

How feasible is at-home antibody testing for COVID-19?

SARS-CoV-2 exposure in England could be double reported seroprevalence

SARS-CoV-2 exposure in England could be double reported seroprevalence

Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in China

Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in China

Reliable Antibodies Testing for SARS-CoV-2

Reliable Antibodies Testing for SARS-CoV-2

Duke-NUS expert joins international taskforce to study the origins of SARS-CoV-2 virus

Duke-NUS expert joins international taskforce to study the origins of SARS-CoV-2 virus